Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001437749-13-000113)

Filing Details

Accession Number:: 0001437749-13-000113
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-01-03 13:17:23
Reporting Period:: 2012-12-11

Filing Date:: 2013-01-03
Accepted Time:: 2013-01-03 13:17:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1389545	Novabay Pharmaceuticals Inc.	NBY	Pharmaceutical Preparations (2834)	680454536

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1565534	Xinzhou Li	Pres. Naqu Area Pioneer Pharma Co. Ltd. No. 1000, Wangqiao Road, Pudong Area Shanghai, P.r. Of China 201201		No	No	Yes	Yes

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-12-11	120,000	$1.20	2,120,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

As President and sole owner of Naqu Area Pioneer Pharma Co. Ltd., the parent company of Pioneer Pharma (Singapore) who owns 2,000,000 shares of NovaBay, Mr. Paul Li is the beneficial owner of such 2,000,000 NovaBay shares.